At last year’s Pharma Pricing & Market Access Europe Frank Weber M.D. took us through an indepth review of the current state of play regarding market access for orphan drugs within the EU. In a presentation entitled “Market access for orphan drugs in EU: the HTA situation 2012-13 in the EU budget crisis” Weber looks at the differing roles between individual European health technology assessment (HTA) organisations.
Download the presentation and and learn about:
- History and Framework of Orphan Disease Market
- Overview on the current status of HTA assessments in OD in EU
- Patient advocacy
- Medical Need
- Outcome parameter
Missed last years event? Well there’s good news as the 8th annual Pharma Pricing and Market Access Outlook World Europe is just around the corner. This February London will host the industries larget pharma pricing and market access event. Bringing in the key players from accross europe, there is unparalleled access to industry experts, executives, suppliers and customers.
To find out more, why not go to our website for more details.